Clinical Trial Update: Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating apatinib in combination with liposomal irinotecan for refractory or metastatic osteosarcoma; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Apatinib (apatinib)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Osteosarcoma, Osteosarcoma Metastatic | Phase 1, Phase 2 | Status: RECRUITING